The effects of Femore (TM) cream on sexual dysfunction in Turkish women

Basit Öğe Kaydı
dc.contributor.authorSen, Selma
dc.contributor.authorGuneri, Sezer E.
dc.contributor.authorSevil, Umran
dc.contributor.authorCengel, Selmin
dc.date.accessioned2019-10-27T22:15:21Z
dc.date.available2019-10-27T22:15:21Z
dc.date.issued2014
dc.departmentEge Üniversitesien_US
dc.description.abstractAims and objectives To investigate the effects of Femore (TM) cream on sexual dysfunction in menopause and women's satisfaction levels. Background The recent interest of public and the world of medicine in female sexual function have led to a rapid increase in the number of studies on the subject. Design The study was designed as an observational intervention study. Methods The research data were collected by using a Women Information Form consisting of 13 items; a Sexual Function Index to measure sexual function; and a Satisfaction Determination Form to determine the level of satisfaction with the medical service the women received for the problems with their reproductive organs. The study was conducted with 29 menopausal women who complied with the inclusion criteria. Results It was found that women's average age was 52 center dot 6; that the average menarche age was 13 center dot 0; and that the average menopause age was 46 center dot 2. The major complaint of nearly all the women who were aware of their sexual dysfunction was vaginal dryness, and it was concluded that they took no precautions against this problem. The total scores obtained from the Sexual Function Index were reported to be an average of 18 center dot 8 +/- 4 center dot 2 before use of Femore (TM) cream and an average of 42 center dot 3 +/- 2 center dot 0 after use of Femore (TM) cream. The average score concerning satisfaction with the use of Femore (TM) cream was noted to be 9 center dot 06 +/- 0 center dot 40. Conclusions The study results suggested that applying Femore (TM) cream had positive influences on sexual dysfunction and all subdomains. Relevance to clinical practice Women's sexual health can therefore be assessed at primary care centres, and it is considered that health professionals employed at these centres, a majority of whom are female nurses and obstetricians, can play an important role in guiding women on the issue.en_US
dc.description.sponsorshipKent Medical International Trade Co., Ltd.en_US
dc.description.sponsorshipSupport was received from the manufacturers of Femore (TM) cream in giving free samples to the participant women. Support for this research was provided by the Kent Medical International Trade Co., Ltd. The funding sources did not intervene in the study design or during the implementation of the study, nor did they take any part in data collection, management, analysis and interpretation. The researchers were allowed to work freely during preparation, review or approval of the manuscript as well.en_US
dc.identifier.doi10.1111/jocn.12389en_US
dc.identifier.endpage1402en_US
dc.identifier.issn0962-1067
dc.identifier.issn1365-2702
dc.identifier.issue09.Octen_US
dc.identifier.pmid24251921en_US
dc.identifier.startpage1395en_US
dc.identifier.urihttps://doi.org/10.1111/jocn.12389
dc.identifier.urihttps://hdl.handle.net/11454/50160
dc.identifier.volume23en_US
dc.identifier.wosWOS:000334178300025en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofJournal of Clinical Nursingen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectmenopauseen_US
dc.subjectsexualityen_US
dc.subjectsexual healthen_US
dc.titleThe effects of Femore (TM) cream on sexual dysfunction in Turkish womenen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu